In Topamax Birth-Defect Case, Phila. Jury Awards $3 Million to Parents

, The Legal Intelligencer

   | 1 Comments

The parents of a child born with a cleft lip and palate linked to the mother's use of the anti-seizure drug Topamax during pregnancy have received a $3 million jury award in a failure-to-warn case in Philadelphia.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisNexis® Here

Not a LexisNexis® Subscriber?

Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • not available

    Rose Pinto has done a consistently outstanding job in representing seriously injured individuals in these pharmaceutical cases and with the highest ethical standards. She is to be congratulated for this latest victory.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202646577810

Thank you!

This article's comments will be reviewed.